Sandra Pyda, MD | |
200 Sw 62nd Blvd, Gainesville, FL 32607-6030 | |
(352) 376-8211 | |
(352) 373-7594 |
Full Name | Sandra Pyda |
---|---|
Gender | Female |
Speciality | Family Medicine |
Location | 200 Sw 62nd Blvd, Gainesville, Florida |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578191185 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | ME160195 (Florida) | Secondary |
207Q00000X | Family Medicine | ME160195 (Florida) | Primary |
Entity Name | Hospital Internal Medicine Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1356495204 PECOS PAC ID: 8022912914 Enrollment ID: O20031121000689 |
News Archive
As a proud member of FEMA's National Preparedness Month Coalition, the California Pharmacists Association has coordinated with pharmacies throughout the state to help citizens prepare for emergencies and natural disasters in their area. The theme of this year's National Preparedness Month is "Resolve to be Ready."
CNS Protein Therapeutics, Inc., a privately held biotechnology company developing first-in-class disease–modifying treatments that address the underlying cause of cell death associated with a wide range of diseases, has completed a corporate name change to Amarantus Therapeutics, Inc. ("Amarantus") and appointed prominent biotechnology industry executive, Martin D. Cleary, as Chief Executive Officer.
Nutritional scientists at the University of Alberta are the first to establish a connection between high insulin levels and dysfunction of intestinal lipid metabolism in an animal model.
Disease-modifying antirheumatic drugs should be used early and aggressively at the first sign of rheumatoid arthritis. The results of an 11-year trial, published in BioMed Central's open access journal Arthritis Research & Therapy, demonstrate that active treatment from the very beginning pays off, even in the long run.
› Verified 6 days ago
Entity Name | Trenton Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1801826268 PECOS PAC ID: 2365359387 Enrollment ID: O20050428000865 |
News Archive
As a proud member of FEMA's National Preparedness Month Coalition, the California Pharmacists Association has coordinated with pharmacies throughout the state to help citizens prepare for emergencies and natural disasters in their area. The theme of this year's National Preparedness Month is "Resolve to be Ready."
CNS Protein Therapeutics, Inc., a privately held biotechnology company developing first-in-class disease–modifying treatments that address the underlying cause of cell death associated with a wide range of diseases, has completed a corporate name change to Amarantus Therapeutics, Inc. ("Amarantus") and appointed prominent biotechnology industry executive, Martin D. Cleary, as Chief Executive Officer.
Nutritional scientists at the University of Alberta are the first to establish a connection between high insulin levels and dysfunction of intestinal lipid metabolism in an animal model.
Disease-modifying antirheumatic drugs should be used early and aggressively at the first sign of rheumatoid arthritis. The results of an 11-year trial, published in BioMed Central's open access journal Arthritis Research & Therapy, demonstrate that active treatment from the very beginning pays off, even in the long run.
› Verified 6 days ago
Entity Name | Signify Health Medical Associates Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1750845863 PECOS PAC ID: 2163764424 Enrollment ID: O20191209002247 |
News Archive
As a proud member of FEMA's National Preparedness Month Coalition, the California Pharmacists Association has coordinated with pharmacies throughout the state to help citizens prepare for emergencies and natural disasters in their area. The theme of this year's National Preparedness Month is "Resolve to be Ready."
CNS Protein Therapeutics, Inc., a privately held biotechnology company developing first-in-class disease–modifying treatments that address the underlying cause of cell death associated with a wide range of diseases, has completed a corporate name change to Amarantus Therapeutics, Inc. ("Amarantus") and appointed prominent biotechnology industry executive, Martin D. Cleary, as Chief Executive Officer.
Nutritional scientists at the University of Alberta are the first to establish a connection between high insulin levels and dysfunction of intestinal lipid metabolism in an animal model.
Disease-modifying antirheumatic drugs should be used early and aggressively at the first sign of rheumatoid arthritis. The results of an 11-year trial, published in BioMed Central's open access journal Arthritis Research & Therapy, demonstrate that active treatment from the very beginning pays off, even in the long run.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Sandra Pyda, MD 1147 Nw 64th Ter, Gainesville, FL 32605-4218 Ph: (352) 333-5152 | Sandra Pyda, MD 200 Sw 62nd Blvd, Gainesville, FL 32607-6030 Ph: (352) 376-8211 |
News Archive
As a proud member of FEMA's National Preparedness Month Coalition, the California Pharmacists Association has coordinated with pharmacies throughout the state to help citizens prepare for emergencies and natural disasters in their area. The theme of this year's National Preparedness Month is "Resolve to be Ready."
CNS Protein Therapeutics, Inc., a privately held biotechnology company developing first-in-class disease–modifying treatments that address the underlying cause of cell death associated with a wide range of diseases, has completed a corporate name change to Amarantus Therapeutics, Inc. ("Amarantus") and appointed prominent biotechnology industry executive, Martin D. Cleary, as Chief Executive Officer.
Nutritional scientists at the University of Alberta are the first to establish a connection between high insulin levels and dysfunction of intestinal lipid metabolism in an animal model.
Disease-modifying antirheumatic drugs should be used early and aggressively at the first sign of rheumatoid arthritis. The results of an 11-year trial, published in BioMed Central's open access journal Arthritis Research & Therapy, demonstrate that active treatment from the very beginning pays off, even in the long run.
› Verified 6 days ago
Rose Michele Emery, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1600 Sw Archer Rd, Gainesville, FL 32610 Phone: 352-392-1161 Fax: 352-846-1422 | |
Dr. Sophia Vanood, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 635 Sw 4th Ave, Family Medicine, Gainesville, FL 32601 Phone: 352-273-5159 | |
Maulik Jitesh Jani, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6500 W Newberry Rd, Gainesville, FL 32605 Phone: 412-439-4915 | |
Dr. Kiona R Subramanian, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 6228 Nw 43rd St, Suite B, Gainesville, FL 32653 Phone: 352-332-6680 Fax: 352-332-6604 | |
Dr. Xai Ma, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1621 Ne Waldo Rd, Gainesville, FL 32609 Phone: 352-955-5540 Fax: 352-373-5326 | |
Jason Wittlin, FNP-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 Sw Archer Rd, Gainesville, FL 32610 Phone: 352-273-8656 | |
Cindy Marie Barbosa Nunez, Family Medicine Medicare: Medicare Enrolled Practice Location: 1707 N Main St, Gainesville, FL 32609 Phone: 352-265-1234 |